Mindfulness may ease anxiety, depression, and brain fog in menopause
Mindfulness's clearest menopause win is psychosocial quality of life, while anxiety, depression, and brain fog still need sturdier trials.

Ten controlled studies involving 1,270 women in six countries produced a pooled signal favoring mindfulness for psychosocial quality of life. The King's College London team put that finding in a larger context: most women experience natural menopause between 45 and 55, after 12 months without menstruation, and some go through it before 40. More than 750 million women worldwide are between 40 and 60, and WHO-linked estimates put the menopausal or post-menopausal population at about 1.2 billion by 2030.
What the review actually found
The cleanest result landed in psychosocial quality of life. Six studies used the MENQOL Psychosocial Domain, which gave the authors enough consistency to pool the data, and the exploratory meta-analysis found a large effect in favor of mindfulness-based interventions, Hedges' g = -1.06, p < 0.001. That is not the same thing as saying mindfulness cures menopause, or even that it should replace other care.
The rest of the evidence is still more uneven. The review looked for anxiety, depression, and cognitive function, but only 10 controlled studies met criteria, eight randomized and two quasi-experimental, so the body of data is still too small to support broad claims about every outcome. That is the same pattern seen in an earlier 2022 meta-analysis of 13 studies and 1,138 menopausal women: stress improved, but anxiety and depression did not reach statistical significance.
What kind of mindfulness was studied
In menopause research, mindfulness usually means a structured program, not a vague instruction to be calmer. The review searched PubMed, Embase, PsycInfo, CINAHL, and Web of Science through October 2025, and it included randomized and non-randomized controlled trials rather than loose observational reports. In the broader menopause literature, the interventions that anchor this evidence base are concrete and time-limited: one randomized trial used an eight-week mindfulness-based stress reduction course after risk-reducing salpingo-oophorectomy, and another trial in 120 menopausal women used seven mindfulness sessions.
These are guided practices repeated over several weeks, with a clear start and finish. Mindfulness-based interventions are positioned as a potentially safe self-managing option or a complement to medication, not a replacement for medical care.
Where it sits alongside the rest of menopause care
Mindfulness is low-cost, adaptable, and carries minimal risk. It can help when symptoms are emotional, cognitive, and hard to pin to one lab value or one prescription. The menopausal transition can last several years and can affect physical, emotional, mental, and social well-being.

Brain fog should stay on the radar here. The Menopause Society says many women complain of brain fog, including forgetfulness, trouble concentrating, and mental fatigue, and its practice material notes that cognitive function at midlife is influenced by menopause stage and by sleep and mood symptoms. Mindfulness may help with strain, but the evidence does not support a claim that it directly fixes cognitive change itself.
CBT still has the stronger track record for some menopause symptoms. The Menopause Society includes cognitive behavioral therapy among recommended nonhormone options for hot flashes, and recent review literature continues to treat it as a well-supported behavioral option in menopause care.
How to put the evidence to use
If you want to try it, choose a guided program with a clear structure, not just a random app streak. The studied interventions were multi-session courses, and the best current signal sits in psychosocial quality of life, so track the same thing in your own life: irritability, rumination, social strain, concentration, and whether your days feel less frayed. A practical test is simple: give a real program several weeks, note whether your mental load drops, and keep your clinician in the loop if you are already managing anxiety, depression, sleep problems, or hormone-related care.
This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.
Did this article answer your question?


